3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Recurrence
2
Lymphoma, T-Cell, Peripheral
1
Lymphoma, B-Cell
1
Lymphoma
1
Burkitt Lymphoma
1
Interventions
Cyclophosphamide
217
Rituximab
110
Etoposide
99
Peripheral Blood Stem Cell Transplantation
94
Vincristine
91
Filgrastim
91
Cytarabine
91
Methotrexate
90
fludarabine phosphate
85
Radiotherapy
67
Doxorubicin
67
Prednisone
66
Dexamethasone
57
Mycophenolic Acid
53
Cyclosporine
53
Whole-Body Irradiation
50
Busulfan
47
Melphalan
44
blinatumomab
43
Tacrolimus
42
fludarabine
41
Antilymphocyte Serum
40
Methylprednisolone
39
merphos
35
Calcium Dobesilate
34
Leucovorin
33
Granulocyte Colony-Stimulating Factor
30
Mercaptopurine
26
dexamethasone acetate
25
dexamethasone 21-phosphate
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Burkitt Lymphoma
×
Immunoconjugates
×
Lymphoid
×
Clear all
NCT06796517
2025-01-28
Immunotherapy in Lymphoma
Seoul St. Mary's Hospital
Recruiting
72 enrolled